Sunbin P. Ling
79 Qingchun Road
Hangzhou, 310003, China
Hangzhou, 310003, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 58 publications
Gastrointestinal conventional carcinoma with neuroendocrine differentiation: From pathological phenomenon to clinical importance (Review).
Journal: Oncology letters
Published: April 06, 2026
Identification of telomere-related gene signatures for immune cell infiltration and prognosis in hepatocellular carcinoma.
Journal: Translational cancer research
Published: March 03, 2026
USP22 inhibition potentiates GPC3 chimeric antigen receptor macrophages efficacy in hepatocellular carcinoma by downregulating tumor CD24 expression.
Journal: Cancer letters
Published: October 21, 2025
Pre-operative risk assessment of hepatocellular carcinoma recurrence in liver transplant recipients by non-invasive detection of pre-existing genetic lesions.
Journal: Clinical and molecular hepatology
Published: September 24, 2025
Stemness- and hypoxia-based prognostic stratification index reveals G6PD as a regulator of hypoxia-driven stemness in hepatocellular carcinoma.
Journal: Frontiers in immunology
Published: July 19, 2025
De Novo Malignancies Post-Liver Transplantation: A Focused Review on Risks, Surveillance and Management.
Journal: Critical reviews in oncology/hematology
Published: March 27, 2025
FGF7 promotes load-bearing tendon regeneration and suppresses fibrosis.
Journal: Nature communications
Published: March 21, 2025
METTL4 and METTL5 as biomarkers for recurrence-free survival in hepatocellular carcinoma patients.
Journal: Future oncology (London, England)
Published: December 20, 2024
Unveiling the Role of Mechanical Microenvironment in Hepatocellular Carcinoma: Molecular Mechanisms and Implications for Therapeutic Strategies.
Journal: International journal of biological sciences
Published: August 23, 2024
Clinical challenges and research perspectives in liver transplant oncology.
Journal: Chinese medical journal
Published: May 23, 2024
The p-MYH9/USP22/HIF-1α axis promotes lenvatinib resistance and cancer stemness in hepatocellular carcinoma.
Journal: Signal transduction and targeted therapy
Published: January 25, 2024
TP53/mTORC1-mediated bidirectional regulation of PD-L1 modulates immune evasion in hepatocellular carcinoma.
Journal: Journal for immunotherapy of cancer
Published: October 25, 2023
Last Updated: 09/26/2026